VYKAT XR FDA approval date

The FDA approved VYKAT XR on 26 Mar 2025.

FDA approval date
26 Mar 2025

Drug identity has not yet been verified against registry records

Also recorded as DIAZOXIDE CHOLINE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-03-26DayVYKAT XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA216665", "applicant_as_listed_by_fda": "SOLENO", "brand_names": ["VYKAT XR"], "active_ingredients": ["DIAZOXIDE CHOLINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250326", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026